Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors | MicrobiomeTrials← Back to trialsNCT02276053
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors
CompletedOBSERVATIONAL
Trial Details
Start: 2014-11-27Est. Completion: 2017-12-04
Enrollment target: 93 participants Locations- 337, Lille, France
- 334, Lyon, France
- 335, Paris, France
- 491, Bonn, Germany
- 493, Freiburg im Breisgau, Germany
- 492, Regensburg, Germany
- 494, Tübingen, Germany
- 398, Ancona, Italy
- 397, Lecco, Italy
- 394, Milan, Italy
- 391, Perugia, Italy
- 392, Roma, Italy
- 396, Roma, Italy
- 395, San Fermo della Battaglia, Italy
- 393, Torino, Italy
- 399, Venezia, Italy
- 311, Amsterdam, Netherlands
- 312, Leidschendam, Netherlands
- 314, Tilburg, Netherlands
- 341, Badalona, Spain
- 344, Barcelona, Spain
- 443, Edgbaston, United Kingdom
- 441, Edinburgh, United Kingdom
- 442, London, United Kingdom
Other microbiome trials you might be interested in
Brain Tumor Related Epilepsy (BTRE)
This is a supportive care study to assess the effect of Vitamin B6 supplementation on mood-related side effects of levet…
Durham, United StatesEst. completion May 31, 2027